Texas A&M Football

Pick 'Em & Rip 'Em sponsored by PrizePicks: Week 12

PrizePicks is your go-to stop for daily fantasy sports, and before you set your lineup for Week 12 of the college football season, our DFS expert Matthew Dawson offers you his insight on the best picks and plays from Texas A&M-South Carolina and beyond! We pick 'em, you rip 'em!
By Matthew Dawson
November 12, 2025
611 Views
Discuss
Story Poster

Use code ‘TEXAGS’ when you sign up and instantly get $50 when you play your first $5+ lineup! Even if your lineup doesn’t win, you’ll still receive the $50 bonus! Click HERE to get started!

The Texas A&M Aggies are 9-0 and headed back to Kyle Field for the first time since downing Florida on Oct. 11. Conference races are heating up across the board, and midweek college football is in full swing.

To view this content, you must be a TexAgs Premium subscriber.
Get Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Luke Evangelist Rara Thomas Dante Moore Nico Iamaleava Pick 'Em & Rip 'Em PrizePicks Colton Joseph Lotzeir Brooks Ethan Grunkemeyer Tawee Walker DeJuan Williams Devon Dampier
Show All
Texas A&M vs. South Carolina EJ Smith Rueben Owens II Football Texas A&M Utah Maryland South Carolina Michigan State Ohio State Penn State UCLA Alabama Cincinnati Troy Old Dominion Oregon 2025
SPONSORED BY
PrizePicks
More Football
See All →
B-Team: Eating garlic knots, betting favorites for the LSU job & more
By Ryan Brauninger
The Film Room: Texas A&M 38, Missouri 17
By Stephen McGee
Around CFB: 'Unfit' CFP committee leaves A&M stagnant at No. 3
By Olin Buchanan
Tale of the Tape: No. 3 Texas A&M vs. South Carolina
By TexAgs
Discussion from...

Pick 'Em & Rip 'Em sponsored by PrizePicks: Week 12

299 Views | 0 Replies | Last: 9 hrs ago by Matthew Dawson
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.